Feiteng Lu
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
- Oncology 12
- Cancer Immunotherapy and Biomarkers 4
- Inflammatory Biomarkers in Disease Prognosis 3
- Colorectal Cancer Treatments and Studies 2
-
- PI3K/AKT/mTOR signaling in cancer 3
- Co-authors
- Hongyun Zhao (12 shared papers)Fan Luo (13 shared papers)Yan Huang (11 shared papers)Jiaxin Cao (9 shared papers)Wenjuan Ma (8 shared papers)Jianhua Zhan (6 shared papers)Siwei Zhang (1 shared paper)Donald Maxwell Parkin (1 shared paper)
- Journals
- Cell Death and Disease (2 papers)Cellular and Molecular Immunology (1 paper)Parasitology (1 paper)European Journal of Cancer Prevention (1 paper)Lipids in Health and Disease (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Feiteng Lu
21 papers receiving 303 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 77
- Oncology 102
- Immunology 63
- Ophthalmology 21
- Pulmonary and Respiratory Medicine 57
Countries citing papers authored by Feiteng Lu
This map shows the geographic impact of Feiteng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiteng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiteng Lu more than expected).
Fields of papers citing papers by Feiteng Lu
This network shows the impact of papers produced by Feiteng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiteng Lu. The network helps show where Feiteng Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feiteng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 57 | |
| 2 | 2005 | 39 | |
| 3 | 2023 | 37 | |
| 4 | 2018 | 26 | |
| 5 | 2018 | 24 | |
| 6 | 2021 | 19 | |
| 7 | 2023 | 16 | |
| 8 | 2021 | 13 | |
| 9 | 2019 | 13 | |
| 10 | 2019 | 12 | |
| 11 | 2019 | 12 | |
| 12 | 2021 | 11 | |
| 13 | 2017 | 9 | |
| 14 | 2022 | 4 | |
| 15 | 2024 | 3 | |
| 16 | 2020 | 3 | |
| 17 | 2022 | 2 | |
| 18 | 2020 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 1 |
About Feiteng Lu
Feiteng Lu is a scholar working on Oncology, Molecular Biology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 306 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Cancer, Lipids, and Metabolism (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Mechanisms and Therapy (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Complement system in diseases (2 papers). The work is most often cited by research in Cancer Research (77 citations), Oncology (102 citations), Immunology (63 citations), Ophthalmology (21 citations) and Pulmonary and Respiratory Medicine (57 citations). Feiteng Lu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Hongyun Zhao, Fan Luo, Yan Huang, Jiaxin Cao, Wenjuan Ma, Jianhua Zhan, Siwei Zhang, Donald Maxwell Parkin, Sarah Whelan and Ting Zhou. Their work appears in journals such as Cell Death and Disease, Cellular and Molecular Immunology, Parasitology, European Journal of Cancer Prevention and Lipids in Health and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.